This four-day course covers issues in regulatory science for gene and cell-therapy medicinal products. 

It's accredited by the Royal College of Pathologists

It's aimed at those involved in the production, testing and registration of advanced therapy medicinal products (ATMPs). 

You'll find out about:

  • the current state of gene/cell therapy development, production technology and regulation
  • the ethics, clinical trial designs and commercial licensing issues

As a wide range of novel gene and/or cell therapies are developed in clinical and preclinical studies, the important question of how to deliver potentially beneficial therapies to patients is often neglected.  

In this course we'll discuss the regulations required to help make future medicinal products safe and effective, which evolve alongside advances in science and technology.